The conventional full threshold perimetry parameters (mean (SD) showed a significant difference of CPSD between brinzolamide and placebo after treatment (ANOVA for repeated measures), but neither brinzolamide nor placebo significantly changed CPSD in the subgroup analysis (Bonferroni-Dunn)
| Brinzolamide | Placebo | |||
|---|---|---|---|---|
| Baseline | Drug | Baseline | Placebo | |
| MD = mean defect, PSD = pattern standard deviation, SF = short term fluctuation, CPSD = corrected pattern standard deviation. | ||||
| MD (dB) | −1.00 (0.85) | −1.14 (1.26) | −1.44 (0.84) | −0.88 (0.81) |
| PSD (dB) | 1.68 (0.27) | 1.79 (0.58) | 1.73 (0.34) | 1.52 (0.32) |
| SF (dB) | 1.47 (0.58) | 1.20 (0.36) | 1.29 (0.40) | 1.32 (0.63) |
| CPSD (dB) | 0.79 (0.62) | 1.19 (0.72) | 0.95 (0.51) | 0.55 (0.56) |